Gralise tablet is developed by Depomed and is licensed to Abbott Products in US, Mexico and Canada.
The FDA has approved Gralise tablets as once daily treatment of post-herpetic neuralgia (PHN), which is pain following healing of the rash associated with shingles.
Depomed is a specialty pharmaceutical company with one approved product on the market and has developed another approved product, Glumetza.